
On stage at Reuters Events’ Transform Food & Agriculture USA 2026, held Oct. 27–28 at the Hyatt Regency Minneapolis.
Minneapolis · October 29, 2026 · 5-minute read
MINNEAPOLIS — If you want to know where food tech is headed next, start with the problems Big Food admits it cannot solve alone.
This week those problems were printed on the agenda, then repeated back from the audience. Reuters Events’ Transform Food & Agriculture USA 2026 brought about 200 executives to the Hyatt Regency Minneapolis on Oct. 27–28 under the theme “From Risk to Resilience.” The organizer built the summit around one stalemate, who pays for transformation, and conceded that “no single enterprise can solve this alone.”
On Day 2, organizers put the top questions from the Day 1 audience on screen. The list read like a brief written for the food tech community:
The room’s top four questions
Who pays for regenerative agriculture?
Measuring what matters: data, metrics and ROI
Turning consumer interest into demand
Scaling innovation across the food system
Speakers on the program included executives from Mondelēz International, Cargill, Mars, PepsiCo, General Mills, Land O’Lakes, Hormel Foods, Bunge, McDonald’s, Target, Chobani and La Colombe, Tate & Lyle and The Magnum Ice Cream Company. Cargill, AgriNovus Indiana, Bay State Milling, the American Egg Board and Business Location Switzerland were Gold Sponsors. Here is what the nation’s largest food companies put on the table, and who in food tech is working on it.
01 Supply that holds up
The problem: Cargill sent its chief technology officer to the Day 2 keynote and the group president of its Food North America business to talk about what keeps food moving. Weather, trade and input costs are now board-level risks.
The pressure comes from every direction. One Day 2 presentation listed geopolitics, trade policy, energy, conflict and a K-shaped economy as the backdrop. It also noted that two of U.S. agriculture’s top five export customers have shrinking populations and a third is flat. The customer base for American crops is getting smaller and older.
Who’s building: Crop intelligence, commodity forecasting and supply chain traceability that give buyers earlier warning and more options. Cropin and Vesper were among the technology providers on the agenda.
Our view: Resilience used to mean extra inventory. Now it means better information, sooner.
The problem: Sustainability leaders from General Mills and Bunge, joined by WWF, debated what farm-level data CPGs need for Scope 3 reporting, and how to get it without overloading growers.
“Measuring what matters” was the audience’s second question. Every buyer wants farm data, few have agreed on what to ask for, and the farmer usually does the paperwork for free.
Who’s building: Measurement, reporting and verification (MRV) platforms, remote sensing, soil measurement and farmer apps that pay growers for their data. Vaisala ran a roundtable on measuring regenerative agriculture.
Our view: The winners will turn farm data into a revenue line for growers, not a compliance chore.
03 Regenerative at scale
The problem: Executives from Tate & Lyle and Pernod Ricard joined a regenerative agriculture keynote panel. The Day 2 keynote, with Mondelēz’s chief R&D officer, Mars’ chief R&D, procurement and sustainability officer, Cargill’s CTO and a leader from U.S. Co-ops, took on who funds the transition.
“Who pays for regenerative agriculture?” topped the audience’s list. Farmers carry the upfront cost and the yield risk. Brands book the Scope 3 benefit years later.
Who’s building: Biologicals that replace synthetic inputs, outcome-based payment platforms and transition financing. Sumitomo Biorational was on the program.
Our view: Contracts that share the cost across the chain, and pay for verified outcomes, are the missing piece.
04 “Healthy,” redefined
The problem: Land O’Lakes, Hormel, Magnum and Bay State Milling debated “optics vs. outcomes” as consumers move away from ultra-processed foods and synthetics. PepsiCo’s chief science officer discussed protein, fiber and hydration as real dietary gaps.
AgriNovus Indiana’s Food is Health presentation put numbers behind the shift. According to its slides, 90% of the $4.5 trillion the U.S. spends on healthcare goes to chronic conditions. About 12% of U.S. adults say they are taking a GLP-1, and another 30 to 35% say they are interested. Four in 10 shoppers changed their diet in the past year to improve their health, and 56 to 58% say they would pay 10% more for healthier ingredients. GLP-1 households buy 44% more fresh produce and 35% more packaged protein while spending 5.3% less on groceries overall.
The market is sizable. The same slides put functional foods and ingredients at $120 billion to $335 billion today, and Food is Medicine and medical nutrition at $15 billion to $85 billion.
Who’s building: AI-driven formulation (Uncountable was on the agenda), fiber and protein ingredients, precision fermentation, upcycled ingredients and personalized nutrition.
Our view: One slide showed demand moving downstream to consumers, retailers and brands, while inputs and genetics, including gene editing and specialty crops, see the least activity. That gap is an opening for ag-biotech founders.
05 The rules are moving to the states
The problem: The AgriNovus presentation tracked state food additive legislation growing from 4 bills in 3 states in 2023 to more than 140 bills in 38 states in 2025. Its slides counted 22 states restricting soda and candy purchases with SNAP benefits, and enacted statutes now binding food companies in New York, West Virginia, California and Arizona. Federal action on dietary guidelines and the “healthy” rule is influential, the slides noted, but slower.
Minnesota’s agriculture commissioner opened Day 1 with the state’s pitch to be a national center for food, fuel and fertilizer.
Who’s building: Regulatory intelligence, clean-label reformulation and ingredient substitution tools, and compliance software built for a patchwork of state rules.
Our view: For startups, regulatory fluency is now a selling point, not overhead.
06 Someone has to pay
The problem: Resilience costs money now and often pays back later, to someone else in the chain. That is the stalemate the whole summit was built around.
New payers are arriving in pockets. Per the AgriNovus slides, Medicaid in some states and some Medicare Advantage plans already pay for medically tailored meals, mostly short term and tied to a diagnosis. Employers cover the drug but rarely the food.
Who’s building: Venture investors and corporate innovation programs. Bread & Butter Ventures, Manna Tree and EcoTech Capital were on the speaker list. Mars’ Unreasonable Food program named 13 ventures from six countries to its third cohort in September. “Addressing the challenges in our food system is a task bigger than any one organization,” Mars’ chief R&D officer said at the time.
Our view: Healthcare dollars could become the next source of funding for better food, if startups can prove outcomes.
What it means
For founders
Speak the buyer’s language: Scope 3, margin, supply security and health outcomes, not only mission. Bring data early, because measuring what matters was the room’s second question. Find the corporate door, whether an accelerator, a venture arm or a co-development pilot. And look upstream, where Food is Health investment is thinnest.
For corporates
Publish your problem list. Fund pilots, not only panels. Standardize data requests so startups can build once and sell to many. Share regulatory expertise with partners who can’t yet afford a compliance team, and pay for outcomes you can verify.
The Food Tech Weekly take
The summit’s honest admission, that no company can fix this alone, is the opening food tech has been waiting for. Partnership is the practical answer to “who pays”: corporates fund pilots and scale, founders absorb the early risk, farmers get paid for outcomes and, increasingly, healthcare may help foot the bill.
The audience’s four questions are a ready-made agenda for every corporate and startup conversation that follows this week. Startups were still a thin slice of the voices on stage in Minneapolis. Next year, they belong on the keynote panel.
